Symbiotex Bioplastics LogoSymbioTex

VERZION & UNLOC AWARD WINNER

Olivia Simpson and Dr. Mattia Parati award

 From University Idea to Award-Winning Business

Olivia’s journey started at the University of Wolverhampton, where she studied Medical Science and Clinical Practice.

But it wasn’t just academic.

A placement in hospitals exposed a pretty stark reality:

👉 Huge volumes of single-use plastic waste

👉 Very little of it actually being recycled

That observation turned into a business idea — and eventually into SymbioTex.

Fast forward a couple of years and that idea has now:

  • Won a £10,000 entrepreneurship grant from Chancellor Lord Paul

  • Secured another £10,000 from the Verizon Business & Unloc Young Entrepreneurs Competition

  • Competed against 1,100+ applicants across Europe

Not bad for something that started during a degree.

The Science Behind the Business

SymbioTex isn’t just another “eco brand”.

It’s built on real scientific development, led by co-founder Mattia Parati, who specialises in biotechnology and is completing his PhD.

The focus?

👉 Bio-based, biodegradable materials

👉 Designed for 3D printing and manufacturing

👉 Targeting industries with high plastic waste — especially healthcare

This is key.

Because healthcare is one of the hardest sectors to “go green” due to hygiene, safety, and regulatory constraints.

Why This Matters More Than It Looks

It’s easy to read this as a feel-good startup story.

But there are three bigger signals worth paying attention to:

1. The Problem Is Being Solved From the Ground Up

This isn’t about recycling more plastic — it’s about removing the need for it entirely.

2. Innovation Is Coming From New Entrants

Not big corporates. Not legacy manufacturers.

Startups like SymbioTex are moving faster and thinking differently.

3. Funding Is Following Sustainability

Grants, competitions, university backing — all pointing in the same direction:

👉 Sustainable materials = investable, scalable, and commercially viable

What Happens Next?

The next phase for SymbioTex is all about commercial pilots — taking the material from concept and testing into real-world use.

They’re already working with:

  • University-backed accelerator programmes

  • The ERDF Smart Concept Fund

  • Ongoing formulation trials to refine the material

Which means this isn’t theoretical anymore.

It’s moving towards real adoption.

👉 Read the full article on the Express & Stars website